| P50 | author | Tiziana Comito | Q85289721 |
| P2093 | author name string | Marta Scorsetti | |
| | Pietro Mancosu | |
| | Stefano Tomatis | |
| | Pierina Navarria | |
| | Ciro Franzese | |
| | Giacomo Reggiori | |
| | Lucia Di Brina | |
| | Elena Clerici | |
| | Angelo Tozzi | |
| | Cristina Iftode | |
| P2860 | cites work | Liver resection of noncolorectal secondaries | Q77531625 |
| | Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model | Q80336296 |
| | Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy | Q81955941 |
| | Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases | Q83412928 |
| | Radiation therapy for liver metastases | Q84974217 |
| | Stereotactic Body Radiation Therapy in Oligometastatic Ovarian Cancer: A Promising Therapeutic Approach | Q90413537 |
| | Review and uses of stereotactic body radiation therapy for oligometastases | Q26864247 |
| | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | Phase I study of individualized stereotactic body radiotherapy of liver metastases. | Q33383521 |
| | Stereotactic body radiation therapy for colorectal liver metastases | Q33525953 |
| | Surgical treatment and other regional treatments for colorectal cancer liver metastases. | Q33679959 |
| | Molecular biology of liver cancer stem cells | Q33756006 |
| | Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases | Q33874670 |
| | Survival after hepatic resection in metastatic colorectal cancer: a population-based study | Q34604452 |
| | Colorectal metastasis (liver and lung). | Q35036386 |
| | An attempt to clarify indications for hepatectomy for liver metastases from breast cancer | Q35057199 |
| | Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma | Q36073416 |
| | Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013 | Q36258276 |
| | Survival after hepatic resection for colorectal metastases: a 10-year experience | Q36416294 |
| | Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients | Q36757904 |
| | Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome | Q36773155 |
| | Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis | Q37994417 |
| | Non-operative therapies for colorectal liver metastases | Q38398883 |
| | Role of surgical resection for non-colorectal non-neuroendocrine liver metastases | Q39162735 |
| | Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer. | Q40831744 |
| | Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors | Q43635526 |
| | Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history | Q43990247 |
| | Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies | Q45055043 |
| | Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial | Q46529210 |
| | Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases. | Q50490128 |
| | Radiosensitivity Differences Between Liver Metastases Based on Primary Histology Suggest Implications for Clinical Outcomes After Stereotactic Body Radiation Therapy. | Q50624966 |
| | Is liver resection justified for patients with hepatic metastases from breast cancer? | Q51775751 |
| | Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. | Q51803948 |
| | Is Hepatic Resection for Non-colorectal, Non-neuroendocrine Liver Metastases Justified? | Q53395162 |
| | Phase II study on stereotactic body radiotherapy of colorectal metastases. | Q53687868 |
| | The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases. | Q55223014 |
| | Oligometastases revisited | Q56773912 |
| | The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases | Q64099116 |
| | The natural history of primary and secondary malignant tumors of the liver I.The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy | Q72334006 |
| | Hepatic resection in metastatic breast cancer: results and prognostic factors | Q73616333 |
| | Result of liver resection as treatment for metastases from noncolorectal cancer | Q73911585 |
| | Metastasectomy for liver metastases of non-colorectal primaries | Q74829142 |
| | Results of surgical resection of liver metastases from non-colorectal primaries | Q77443199 |
| P433 | issue | 4 | |
| P304 | page(s) | 325-333 | |
| P577 | publication date | 2019-10-11 | |
| P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
| P1476 | title | Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors | |
| P478 | volume | 196 | |